Profil
William Fisher is the founder of Accurate Venture, Inc. He currently holds the positions of President & Chief Executive Officer at Golden Grail Merger Corp.
and Chairman, CEO & Chief Strategist at Leaf Vertical, Inc. Previously, he served as Chief Executive Officer & Director at Golden Grail Technology Corp.
Aktive Positionen von Bill Fisher
| Unternehmen | Position | Beginn |
|---|---|---|
Golden Grail Merger Corp.
Golden Grail Merger Corp. Financial ConglomeratesFinance Provides investment services | Vorstandsvorsitzender | - |
Leaf Vertical, Inc.
Leaf Vertical, Inc. Leaf Vertical, Inc. operates as clinical-stage biopharmaceutical research company, engages in discovering and developing novel therapeutics from its proprietary cannabinoid product platform. It offers BRCX, a new drug delivering a specific dose of a proprietary formula for the treatment of colon cancer. The company is headquartered in Orlando, FL. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Bill Fisher
| Unternehmen | Position | Ende |
|---|---|---|
| GOLDEN GRAIL TECHNOLOGY CORP. | Vorstandsvorsitzender | 07.12.2017 |
Accurate Venture, Inc.
Accurate Venture, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Golden Grail Technology Corp.
Golden Grail Technology Corp. Beverages: Non-AlcoholicConsumer Non-Durables Manufactures and sells beverages | Consumer Non-Durables |
Accurate Venture, Inc.
Accurate Venture, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Golden Grail Merger Corp.
Golden Grail Merger Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Leaf Vertical, Inc.
Leaf Vertical, Inc. Leaf Vertical, Inc. operates as clinical-stage biopharmaceutical research company, engages in discovering and developing novel therapeutics from its proprietary cannabinoid product platform. It offers BRCX, a new drug delivering a specific dose of a proprietary formula for the treatment of colon cancer. The company is headquartered in Orlando, FL. |
















